Orchestrating Transcriptional Control of Adult Neurogenesis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
NIH Public Access Author Manuscript J Neurosci
NIH Public Access Author Manuscript J Neurosci. Author manuscript; available in PMC 2013 May 10. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: J Neurosci. 2008 September 10; 28(37): 9194–9204. doi:10.1523/JNEUROSCI.3314-07.2008. Noggin Expands Neural Stem Cells in the Adult Hippocampus Michael A. Bonaguidi1,2,3,6, Chian-Yu Peng1,6, Tammy McGuire1, Gustave Falciglia1,4, Kevin T. Gobeske1, Catherine Czeisler1,5, and John A. Kessler1 1Davee Department of Neurology. Northwestern University’s Feinberg School of Medicine. 303 E. Chicago Ave, Chicago, IL 60611, USA 2Institute for Cell Engineering, Johns Hopkins University School of Medicine, 733 N. Broadway Ave, Baltimore, MD 21205, USA 3Department of Neurology, Johns Hopkins University School of Medicine, 733 N. Broadway Ave, Baltimore, MD 21205, USA 4Department of Pediatrics. University of Chicago. 5721 S. Maryland Ave, Chicago, IL 60637, USA 5Cardiovascular Research Institute, UCSF. 1554 4thSt, San Francisco, CA 94158, USA Abstract New neurons are added to the adult hippocampus throughout life and contribute to cognitive functions including learning and memory. It remains unclear whether ongoing neurogenesis arises from self-renewing neural stem cells (NSC) or from multipotential progenitor cells that cannot self-renew in the hippocampus. This is largely based on observations that neural precursors derived from the subventricular zone (SVZ) can be passaged long-term whereas hippocampal subgranular zone (SGZ) precursors are rapidly depleted by passaging. We demonstrate here that high levels of BMP signaling occur in hippocampal but not SVZ precursors in vitro, and blocking BMP signaling with Noggin is sufficient to foster hippocampal cell self-renewal, proliferation, and multipotentiality using single cell clonal analysis. -
The Act of Controlling Adult Stem Cell Dynamics: Insights from Animal Models
biomolecules Review The Act of Controlling Adult Stem Cell Dynamics: Insights from Animal Models Meera Krishnan 1, Sahil Kumar 1, Luis Johnson Kangale 2,3 , Eric Ghigo 3,4 and Prasad Abnave 1,* 1 Regional Centre for Biotechnology, NCR Biotech Science Cluster, 3rd Milestone, Gurgaon-Faridabad Ex-pressway, Faridabad 121001, India; [email protected] (M.K.); [email protected] (S.K.) 2 IRD, AP-HM, SSA, VITROME, Aix-Marseille University, 13385 Marseille, France; [email protected] 3 Institut Hospitalo Universitaire Méditerranée Infection, 13385 Marseille, France; [email protected] 4 TechnoJouvence, 13385 Marseille, France * Correspondence: [email protected] Abstract: Adult stem cells (ASCs) are the undifferentiated cells that possess self-renewal and differ- entiation abilities. They are present in all major organ systems of the body and are uniquely reserved there during development for tissue maintenance during homeostasis, injury, and infection. They do so by promptly modulating the dynamics of proliferation, differentiation, survival, and migration. Any imbalance in these processes may result in regeneration failure or developing cancer. Hence, the dynamics of these various behaviors of ASCs need to always be precisely controlled. Several genetic and epigenetic factors have been demonstrated to be involved in tightly regulating the proliferation, differentiation, and self-renewal of ASCs. Understanding these mechanisms is of great importance, given the role of stem cells in regenerative medicine. Investigations on various animal models have played a significant part in enriching our knowledge and giving In Vivo in-sight into such ASCs regulatory mechanisms. In this review, we have discussed the recent In Vivo studies demonstrating the role of various genetic factors in regulating dynamics of different ASCs viz. -
Prox1regulates the Subtype-Specific Development of Caudal Ganglionic
The Journal of Neuroscience, September 16, 2015 • 35(37):12869–12889 • 12869 Development/Plasticity/Repair Prox1 Regulates the Subtype-Specific Development of Caudal Ganglionic Eminence-Derived GABAergic Cortical Interneurons X Goichi Miyoshi,1 Allison Young,1 Timothy Petros,1 Theofanis Karayannis,1 Melissa McKenzie Chang,1 Alfonso Lavado,2 Tomohiko Iwano,3 Miho Nakajima,4 Hiroki Taniguchi,5 Z. Josh Huang,5 XNathaniel Heintz,4 Guillermo Oliver,2 Fumio Matsuzaki,3 Robert P. Machold,1 and Gord Fishell1 1Department of Neuroscience and Physiology, NYU Neuroscience Institute, Smilow Research Center, New York University School of Medicine, New York, New York 10016, 2Department of Genetics & Tumor Cell Biology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, 3Laboratory for Cell Asymmetry, RIKEN Center for Developmental Biology, Kobe 650-0047, Japan, 4Laboratory of Molecular Biology, Howard Hughes Medical Institute, GENSAT Project, The Rockefeller University, New York, New York 10065, and 5Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724 Neurogliaform (RELNϩ) and bipolar (VIPϩ) GABAergic interneurons of the mammalian cerebral cortex provide critical inhibition locally within the superficial layers. While these subtypes are known to originate from the embryonic caudal ganglionic eminence (CGE), the specific genetic programs that direct their positioning, maturation, and integration into the cortical network have not been eluci- dated. Here, we report that in mice expression of the transcription factor Prox1 is selectively maintained in postmitotic CGE-derived cortical interneuron precursors and that loss of Prox1 impairs the integration of these cells into superficial layers. Moreover, Prox1 differentially regulates the postnatal maturation of each specific subtype originating from the CGE (RELN, Calb2/VIP, and VIP). -
Clinical Utility of Recently Identified Diagnostic, Prognostic, And
Modern Pathology (2017) 30, 1338–1366 1338 © 2017 USCAP, Inc All rights reserved 0893-3952/17 $32.00 Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms Arantza Onaindia1, L Jeffrey Medeiros2 and Keyur P Patel2 1Instituto de Investigacion Marques de Valdecilla (IDIVAL)/Hospital Universitario Marques de Valdecilla, Santander, Spain and 2Department of Hematopathology, MD Anderson Cancer Center, Houston, TX, USA Genomic profiling studies have provided new insights into the pathogenesis of mature B-cell neoplasms and have identified markers with prognostic impact. Recurrent mutations in tumor-suppressor genes (TP53, BIRC3, ATM), and common signaling pathways, such as the B-cell receptor (CD79A, CD79B, CARD11, TCF3, ID3), Toll- like receptor (MYD88), NOTCH (NOTCH1/2), nuclear factor-κB, and mitogen activated kinase signaling, have been identified in B-cell neoplasms. Chronic lymphocytic leukemia/small lymphocytic lymphoma, diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, Burkitt lymphoma, Waldenström macroglobulinemia, hairy cell leukemia, and marginal zone lymphomas of splenic, nodal, and extranodal types represent examples of B-cell neoplasms in which novel molecular biomarkers have been discovered in recent years. In addition, ongoing retrospective correlative and prospective outcome studies have resulted in an enhanced understanding of the clinical utility of novel biomarkers. This progress is reflected in the 2016 update of the World Health Organization classification of lymphoid neoplasms, which lists as many as 41 mature B-cell neoplasms (including provisional categories). Consequently, molecular genetic studies are increasingly being applied for the clinical workup of many of these neoplasms. In this review, we focus on the diagnostic, prognostic, and/or therapeutic utility of molecular biomarkers in mature B-cell neoplasms. -
Conserved Functional Motifs of the Nuclear Receptor Superfamily As Potential Pharmacological Targets
INTERNATIONAL JOURNAL OF EPIGenetiCS 1: 3, 2021 Conserved functional motifs of the nuclear receptor superfamily as potential pharmacological targets LOUIS PAPAGEORGIOU1, LIVIA SHALZI1, ASPASIA EFTHIMIADOU2, FLORA BACOPOULOU3, GEORGE P. CHROUSOS3,4, ELIAS ELIOPOULOS1 and DIMITRIOS VLACHAKIS1,3,4 1Laboratory of Genetics, Department of Biotechnology, School of Applied Biology and Biotechnology, Agricultural University of Athens, 11855 Athens; 2Department of Soil Science of Athens, Institute of Soil and Water Resources, Hellenic Agricultural Organization-Demeter, 14123 Lycovrisi; 3University Research Institute of Maternal and Child Health and Precision Medicine, and UNESCO Chair on Adolescent Health Care, National and Kapodistrian University of Athens, ‘Aghia Sophia’ Children's Hospital; 4Division of Endocrinology and Metabolism, Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece Received March 21, 2021; Accepted May 31, 2021 DOI: 10.3892/ije.2021.3 Abstract. Nuclear receptors (NRs) are one of the most diverse organ physiology, cell differentiation and homeostasis (1,2). In and well-reported family of proteins. They are involved in humans, only 48 members of the superfamily have been found numerous cellular processes as they play pivotal roles in and genetic mutations in these NRs have been proven to cause cell signaling and the cell cycle. The participation of NRs rare diseases, such as cancer, diabetes, rheumatoid arthritis, in various applications in medicine and biology has greatly asthma and hormone resistance syndromes (3). Bearing that attracted the interest of the pharmaceutical industry for the in mind and the fact that nuclear hormone receptors possess discovery of novel and/or improved drugs for the treatment internal pockets, that bind to hydrophobic, drug-like molecules, of several diseases, including cancer, diabetes or infertility. -
Regulation of Adult Neurogenesis in Mammalian Brain
International Journal of Molecular Sciences Review Regulation of Adult Neurogenesis in Mammalian Brain 1,2, 3, 3,4 Maria Victoria Niklison-Chirou y, Massimiliano Agostini y, Ivano Amelio and Gerry Melino 3,* 1 Centre for Therapeutic Innovation (CTI-Bath), Department of Pharmacy & Pharmacology, University of Bath, Bath BA2 7AY, UK; [email protected] 2 Blizard Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK 3 Department of Experimental Medicine, TOR, University of Rome “Tor Vergata”, 00133 Rome, Italy; [email protected] (M.A.); [email protected] (I.A.) 4 School of Life Sciences, University of Nottingham, Nottingham NG7 2HU, UK * Correspondence: [email protected] These authors contributed equally to this work. y Received: 18 May 2020; Accepted: 7 July 2020; Published: 9 July 2020 Abstract: Adult neurogenesis is a multistage process by which neurons are generated and integrated into existing neuronal circuits. In the adult brain, neurogenesis is mainly localized in two specialized niches, the subgranular zone (SGZ) of the dentate gyrus and the subventricular zone (SVZ) adjacent to the lateral ventricles. Neurogenesis plays a fundamental role in postnatal brain, where it is required for neuronal plasticity. Moreover, perturbation of adult neurogenesis contributes to several human diseases, including cognitive impairment and neurodegenerative diseases. The interplay between extrinsic and intrinsic factors is fundamental in regulating neurogenesis. Over the past decades, several studies on intrinsic pathways, including transcription factors, have highlighted their fundamental role in regulating every stage of neurogenesis. However, it is likely that transcriptional regulation is part of a more sophisticated regulatory network, which includes epigenetic modifications, non-coding RNAs and metabolic pathways. -
Epidermal Growth Factor Promotes a Neural Phenotype in Thymic
Epidermal Growth Factor Promotes a Neural Phenotype in Thymic Epithelial Cells and Enhances Neuropoietic Cytoldne Expression Isabella Screpanti,* Susanna Scarpa,* Daniela Meco,* Diana BeUavia,~ Liborio Stuppia, § Luigi Frati, *u Andrea Modesti,* and Alberto Gulino I *Department of Experimental Medicine and Pathology, University La Sapienza, 00161 Rome;qnstitute of Human Pathology and Social Medicine, University of Chieti, 66100 Chieti; §Institute of N.P. Human Cytomorphology, National Research Council, 66100 Chieti; and UMediterranean Institute of Neuroscience, Pozzilli and IDepartment of Experimental Medicine, University of L'Aquila, 67100 L'Aquila, Italy Abstract. Neural crest-derived cells populate the thy- growth factor enhances cells that express the genes en- Downloaded from http://rupress.org/jcb/article-pdf/130/1/183/1264385/183.pdf by guest on 29 September 2021 mus, and their coexistence with epithelial cells is re- coding the preprotachykinin A-generated neuropep- quired for proper organ development and T cell educa- tides and the bipotential neuropoietic and lymphopoi- tion function. We show here that epidermal growth etic cytokines ciliary neurotrophic factor and factor (EGF), a major epithelial cell growth-enhancing interleukin-6. These cytokines also enhance the neu- agent, has a morphogenetic action to promote the ex- ronal phenotype of thymic epithelial cells. Therefore, pression of a neuronal phenotype (e.g., neurofilament EGF appears to be a composite autocrine/paracrine expression) in cultured thymic epithelial cells that are neuromodulator in thymic stroma. This suggests that characterized by a cytokeratin-positive epithelial cell EGF may regulate thymus-dependent immune func- background. The proliferation of such neurodifferenti- tions by promoting neuronal gene expression in neural ated cells is also enhanced by EGF. -
Genome-Wide DNA Methylation Analysis of KRAS Mutant Cell Lines Ben Yi Tew1,5, Joel K
www.nature.com/scientificreports OPEN Genome-wide DNA methylation analysis of KRAS mutant cell lines Ben Yi Tew1,5, Joel K. Durand2,5, Kirsten L. Bryant2, Tikvah K. Hayes2, Sen Peng3, Nhan L. Tran4, Gerald C. Gooden1, David N. Buckley1, Channing J. Der2, Albert S. Baldwin2 ✉ & Bodour Salhia1 ✉ Oncogenic RAS mutations are associated with DNA methylation changes that alter gene expression to drive cancer. Recent studies suggest that DNA methylation changes may be stochastic in nature, while other groups propose distinct signaling pathways responsible for aberrant methylation. Better understanding of DNA methylation events associated with oncogenic KRAS expression could enhance therapeutic approaches. Here we analyzed the basal CpG methylation of 11 KRAS-mutant and dependent pancreatic cancer cell lines and observed strikingly similar methylation patterns. KRAS knockdown resulted in unique methylation changes with limited overlap between each cell line. In KRAS-mutant Pa16C pancreatic cancer cells, while KRAS knockdown resulted in over 8,000 diferentially methylated (DM) CpGs, treatment with the ERK1/2-selective inhibitor SCH772984 showed less than 40 DM CpGs, suggesting that ERK is not a broadly active driver of KRAS-associated DNA methylation. KRAS G12V overexpression in an isogenic lung model reveals >50,600 DM CpGs compared to non-transformed controls. In lung and pancreatic cells, gene ontology analyses of DM promoters show an enrichment for genes involved in diferentiation and development. Taken all together, KRAS-mediated DNA methylation are stochastic and independent of canonical downstream efector signaling. These epigenetically altered genes associated with KRAS expression could represent potential therapeutic targets in KRAS-driven cancer. Activating KRAS mutations can be found in nearly 25 percent of all cancers1. -
Rapid and Efficient Generation of Oligodendrocytes from Human
Rapid and efficient generation of oligodendrocytes PNAS PLUS from human induced pluripotent stem cells using transcription factors Marc Ehrlicha,b, Sabah Mozafaric,d,e,f, Michael Glatzab, Laura Starosta,b, Sergiy Velychkob, Anna-Lena Hallmanna,b, Qiao-Ling Cuig, Axel Schambachh, Kee-Pyo Kimb, Corinne Bachelinc,d,e,f, Antoine Marteync,d,e,f, Gunnar Hargusa,b, Radia Marie Johnsoni, Jack Antelg, Jared Sterneckertj, Holm Zaehresb,k, Hans R. Schölerb,l, Anne Baron-Van Evercoorenc,d,e,f, and Tanja Kuhlmanna,1 aInstitute of Neuropathology, University Hospital Münster, 48149 Muenster, Germany; bDepartment of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, 48149 Muenster, Germany; cINSERM, U1127, F-75013 Paris, France; dCNRS, UMR 7225, F-75013 Paris, France; eSorbonne Universités, Université Pierre et Marie Curie Paris 06, UM-75, F-75005 Paris, France; fInstitut du Cerveau et de la Moelle epinière-Groupe Hospitalier Pitié-Salpêtrière, F-75013 Paris, France; gMontreal Neurological Institute, McGill University, Montreal, QC, Canada H3A 2B4; hInstitute of Experimental Hematology, Hannover Medical School, 30625 Hannover, Germany; iDepartment of Physiology, McGill University, Montreal, QC, Canada H3A 2B4; jDFG Research Center for Regenerative Therapies, Technische Universität Dresden, 01307 Dresden, Germany; kMedical Faculty, Department of Anatomy and Molecular Embryology, Ruhr-University Bochum, 44801 Bochum, Germany; and lMedicial Faculty, Westphalian Wilhelms-University of Muenster, 48149 Muenster, Germany Edited by Brigid L. M. Hogan, Duke University Medical Center, Durham, NC, and approved February 1, 2017 (received for review August 30, 2016) Rapid and efficient protocols to generate oligodendrocytes (OL) more, these protocols require long culture periods (70–150 d) to + from human induced pluripotent stem cells (iPSC) are currently obtain O4 OL and show limited efficiency (9–12). -
Stem Cells and Neurological Disease the Transplant Site
J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.74.5.557 on 1 May 2003. Downloaded from EDITORIAL 553 Stem cells shown to survive and ameliorate behav- ................................................................................... ioural deficits in an animal mode of Par- kinson’s disease,3 although in this study 20% of rats still developed teratomas at Stem cells and neurological disease the transplant site. In contrast, Kim et al, using a different approach that relies on R A Barker, M Jain,RJEArmstrong, M A Caldwell transfection with Nurr1 (a transcription ................................................................................... factor involved in the differentiation of dopaminergic cells), have demonstrated The therapeutic implications and application of stem cells for functional efficacy without tumour formation.4 the nervous system Human embryonic stem cells have now been isolated5 and grown in culture with enrichment for neuronal lineages, here has recently been a great deal of (c) ability to migrate and disseminate possible through exposure to a combina- interest in stem cells and the nerv- following implantation within the adult tion of growth factors and mitogens.6 Tous system, in terms of their poten- CNS; These cells, when placed in the develop- tial for deciphering developmental issues (d) possible tropism for areas of path- ing rat brain, can migrate widely and as well as their therapeutic potential. In ology; differentiate in a site specific fashion this editorial we will critically appraise without the formation of teratomas.7 the different types of stem cells, their (e) ease of manipulation using viral and non-viral gene transfer methods; However, the safety of these cells needs therapeutic implications, and the appli- further investigation before they can be (f) ability to better integrate into normal cations to which they have been put, considered for clinical use. -
Orthopedic Surgery Modulates Neuropeptides and BDNF Expression at the Spinal and Hippocampal Levels
Orthopedic surgery modulates neuropeptides and BDNF expression at the spinal and hippocampal levels Ming-Dong Zhanga,1, Swapnali Bardea, Ting Yangb,c, Beilei Leid, Lars I. Erikssonb,e, Joseph P. Mathewd, Thomas Andreskaf, Katerina Akassogloug,h, Tibor Harkanya,i, Tomas G. M. Hökfelta,1,2, and Niccolò Terrandob,d,1,2 aDepartment of Neuroscience, Karolinska Institutet, Stockholm 171 77, Sweden; bDepartment of Physiology and Pharmacology, Section for Anesthesiology and Intensive Care Medicine, Karolinska Institutet, Stockholm 171 77, Sweden; cDivision of Nephrology, Department of Medicine, Duke University Medical Center, Durham, NC 27710; dDepartment of Anesthesiology, Duke University Medical Center, Durham, NC 27710; eFunction Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm 171 76, Sweden; fInstitute of Clinical Neurobiology, University of Würzburg, 97078 Wuerzburg, Germany; gGladstone Institute of Neurological Disease, University of California, San Francisco, CA 94158; hDepartment of Neurology, University of California, San Francisco, CA 94158; and iDepartment of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna, A-1090 Vienna, Austria Contributed by Tomas G. M. Hökfelt, August 25, 2016 (sent for review January 18, 2016; reviewed by Jim C. Eisenach, Ronald Lindsay, Remi Quirion, and Tony L. Yaksh) Pain is a critical component hindering recovery and regaining of shown hippocampal abnormalities in animal models of neuro- function after surgery, particularly in the elderly. Understanding the pathic pain and reduced hippocampal volume in elderly patients role of pain signaling after surgery may lead to novel interventions with chronic pain (10–12). Moreover, changes in regional brain for common complications such as delirium and postoperative volume, including hippocampal and cortical atrophy, have also cognitive dysfunction. -
Single-Cell Transcriptomics Characterizes Cell Types in the Subventricular Zone and Uncovers
bioRxiv preprint doi: https://doi.org/10.1101/365619; this version posted July 9, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Single-cell transcriptomics characterizes cell types in the subventricular zone and uncovers molecular defects underlying impaired adult neurogenesis Vera Zywitza1,+, Aristotelis Misios1,+, Lena Bunatyan2, Thomas E. Willnow2,*, and Nikolaus Rajewsky1,3,* 1 Laboratory for Systems Biology of Gene Regulatory Elements, Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Robert-Rössle-Str. 10, Berlin-Buch, Germany 2 Molecular Cardiovascular Research, Max Delbrück Center for Molecular Medicine, Robert-Rössle- Str. 10, Berlin-Buch, Germany 3 Lead Contact + These authors contributed equally *Correspondence: [email protected]; [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/365619; this version posted July 9, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. SUMMARY Neural stem cells (NSCs) contribute to plasticity and repair of the adult brain. Niches harboring NSCs are crucial for regulating stem cell self-renewal and differentiation. We used single-cell RNA profiling to generate an unbiased molecular atlas of all cell types in the largest neurogenic niche of the adult mouse brain, the subventricular zone (SVZ). We characterized > 20 neural and non-neural cell types and gained insights into the dynamics of neurogenesis by predicting future cell states based on computational analysis of RNA kinetics. Furthermore, we apply our single-cell approach to mice lacking LRP2, an endocytic receptor required for SVZ maintenance.